Author Correction: SGLT2 inhibitors reduce the risk of renal failure in CKD stage 5 patients with Type 2 DM.
Saved in:
| Title: | Author Correction: SGLT2 inhibitors reduce the risk of renal failure in CKD stage 5 patients with Type 2 DM. |
|---|---|
| Authors: | Huang, Birdie1 (AUTHOR), Yen, Chieh-Li2,3 (AUTHOR), Wu, Chao-Yi3 (AUTHOR), Tsai, Chung-Ying2 (AUTHOR), Chen, Jia-Jin2,3 (AUTHOR), Hsiao, Ching-Chung2,3 (AUTHOR), Chen, Yung-Chang2,3 (AUTHOR), Hsieh, I-Chang1 (AUTHOR), Yang, Huang-Yu2,3,4 (AUTHOR) hyyang01@gmail.com |
| Source: | Scientific Reports. 4/11/2025, Vol. 15 Issue 1, p1-1. 1p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20452322 |
|---|---|
| DOI: | 10.1038/s41598-025-96996-3 |